We are live on ! Find out more
NEO icon

NeoGenomics
NEO

119 hedge funds and large institutions have $379M invested in NeoGenomics in 2016 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 32 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

470% more call options, than puts

Call options by funds: $907K | Put options by funds: $159K

41% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 32

0% more funds holding

Funds holding: 119 → 119 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

13% less capital invested

Capital invested by funds: $434M → $379M (-$55.4M)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
119
Holders Change
–
Holders Change %
0%
% of All Funds
3.17%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.16%
New
15
Increased
45
Reduced
32
Closed
15
Calls
$907K
Puts
$159K
Net Calls
+$748K
Net Calls Change
-$127K

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$2.29M
2
RFC
Russell Frank Company
Washington
+$2.27M
3
CPA
Cowen Prime Advisors
New York
+$2M
4
CM
Castleark Management
Illinois
+$1.83M
5
Morgan Stanley
Morgan Stanley
New York
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
William Blair & Company
William Blair & Company
Illinois
-$2.06M
2
Millennium Management
Millennium Management
New York
-$1.52M
3
OAM
Oxford Asset Management
United Kingdom
-$1.17M
4
PAM
Panagora Asset Management
Massachusetts
-$1.12M
5
Invesco
Invesco
Georgia
-$934K
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
26
Pier Capital
Connecticut
$3.54M -$321K -48,723 -8%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$3.49M +$39.9K +6,057 +1%
NC
28
Northpointe Capital
Michigan
$3.48M +$119K +18,119 +4%
GIP
29
Granite Investment Partners
California
$3.3M +$630K +95,777 +24%
RA
30
Royce & Associates
New York
$3.19M +$2.29M +348,000 +278%
GF
31
Gabelli Funds
New York
$3M +$987K +150,000 +51%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.52M +$334K +50,731 +16%
Morgan Stanley
33
Morgan Stanley
New York
$2.43M +$1.56M +236,934 +191%
Renaissance Technologies
34
Renaissance Technologies
New York
$2.26M -$934K -141,900 -30%
USAA
35
United Services Automobile Association
Texas
$2.17M +$259K +39,400 +14%
BA
36
Bard Associates
Illinois
$2.15M -$30.3K -4,600 -1%
NIP
37
Nicholas Investment Partners
California
$2.05M +$623K +94,665 +45%
Ameriprise
38
Ameriprise
Minnesota
$1.9M +$308K +46,835 +20%
HighTower Advisors
39
HighTower Advisors
Illinois
$1.87M – – –
AI
40
Axiom Investors
Connecticut
$1.85M +$855K +129,951 +89%
FNBT
41
FineMark National Bank & Trust
Florida
$1.35M – – –
AI
42
Analytic Investors
California
$1.34M +$589K +89,513 +82%
BIM
43
BlackRock Investment Management
Delaware
$1.29M +$23.5K +3,564 +2%
FPC
44
Falcon Point Capital
California
$1.26M +$137K +20,806 +13%
PPA
45
Parametric Portfolio Associates
Washington
$1.25M +$1.03M +156,398 +533%
TA
46
Teton Advisors
New York
$1.22M – – –
TCM
47
Timpani Capital Management
Wisconsin
$1.13M +$1.11M +168,206 New
TCIM
48
TIAA CREF Investment Management
New York
$1.13M -$160K -24,358 -13%
Invesco
49
Invesco
Georgia
$994K -$934K -141,932 -49%
LTFS
50
Ladenburg Thalmann Financial Services
Florida
$959K +$930K +141,276 +14,128%
1
2
3 4 5

NEO Hedge Fund Activity: Q1 2016 in Review

119 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2016, worth a combined $379M — down 13% from $434M a quarter earlier.

Fund positioning in NEO was balanced in Q1 2016: 15 funds opened new positions, 15 closed out, 45 added to existing stakes and 32 trimmed.

The largest buyer was Royce & Associates, adding an estimated $2.29M. The largest seller was William Blair & Company, cutting an estimated $2.06M.

  • 119 institutional investors held NeoGenomics (NEO) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $379M of NeoGenomics stock for Q1 2016, down 13% quarter-over-quarter.
  • 15 funds opened new NeoGenomics positions in Q1 2016 and 15 closed out, a net change of 0 holders.
  • The largest NeoGenomics buyer in Q1 2016 was Royce & Associates, an estimated $2.29M added.
  • The largest NeoGenomics seller in Q1 2016 was William Blair & Company, an estimated $2.06M sold.

Based on aggregated 13F filings for Q1 2016.